Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Debt Ratio (2020 - 2023)

Kiora Pharmaceuticals (KPRX) has disclosed Debt Ratio for 5 consecutive years, with 0.03 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Debt Ratio rose 75.31% year-over-year to 0.03, compared with a TTM value of 0.03 through Sep 2023, up 75.31%, and an annual FY2020 reading of 0.02, changed N/A over the prior year.
  • Debt Ratio was 0.03 for Q3 2023 at Kiora Pharmaceuticals, up from 0.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q3 2023 and bottomed at 0.01 in Q1 2021.
  • Average Debt Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2020.
  • Peak annual rise in Debt Ratio hit 75.31% in 2023, while the deepest fall reached 19.13% in 2023.
  • Year by year, Debt Ratio stood at 0.02 in 2020, then fell by 25.78% to 0.01 in 2021, then skyrocketed by 31.66% to 0.02 in 2022, then surged by 75.31% to 0.03 in 2023.
  • Business Quant data shows Debt Ratio for KPRX at 0.03 in Q3 2023, 0.02 in Q2 2023, and 0.02 in Q1 2023.